<DOC>
	<DOCNO>NCT01049165</DOCNO>
	<brief_summary>The primary purpose study evaluate safety tolerability single oral dos BMS-813160 healthy subject</brief_summary>
	<brief_title>Single Ascending Dose ( BMS-813160 ) Study</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<criteria>Men woman ( child bear potential ) age 18 45 Healthy subject determine clinically significant deviation normal medical history , physical examination , ECGs , clinical laboratory determination Women Child Bearing Potential Organ dysfunction clinically significant deviation normal medical history , physical examination , ECGs , clinical laboratory determination</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>